KCNH2 and familial long QT syndrome: Matsa et al. used an allele-specific small interfering RNA to knock down the mutated KCNH2 mRNA in LQTS (KCNH2 p.(Ala561Thr)) patient iPSC-CMs thereby preventing the dominant negative-trafficking defect.